Fertility preservation in women with cancer: Importance of a multidisciplinary approach

Women's Health

Volumn 7, Issue 5, 2011, Pages 537-543

  Treves, Rachel ^a   Grynberg, Michaël ^a   Hesters, Laetitia ^a   Frydman, Rene ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

cancer; fertility preservation; oocyte cryopreservation; ovarian tissue transplantation

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; FLUOROURACIL; GONADORELIN AGONIST; METHOTREXATE;

BRCA 1 GENE; BRCA 2 GENE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CRYOPRESERVATION; DRUG CYTOTOXICITY; DRUG EXPOSURE; FERTILITY; FERTILIZATION IN VITRO; GONAD DYSFUNCTION; GRANULOSA CELL; HODGKIN DISEASE; HUMAN; INFERTILITY; IONIZING RADIATION; MEDICAL ETHICS; MENSTRUAL CYCLE; ONCOGENE; OOCYTE; OVARIAN PRESERVATION; OVARIAN RESERVE; OVARY CANCER; OVULATION INHIBITION; PREMATURE OVARIAN FAILURE; RADIATION EXPOSURE; REVIEW; RISK ASSESSMENT; TISSUE PRESERVATION; UTERINE CERVIX CANCER; WOMEN'S HEALTH;

ANTINEOPLASTIC AGENTS, ALKYLATING; CRYOPRESERVATION; CYCLOPHOSPHAMIDE; DECISION MAKING; FEMALE; FERTILITY PRESERVATION; HUMANS; NEOPLASMS;

EID: 80052456260     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/whe.11.40     Document Type: Review

References (68)

1. Blatt J. Pregnancy outcome in long-term survivors of childhood cancer. Med. Pediatr. Oncol. 33(1), 29-33 (1999).
2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics. CA Cancer J. Clin. 57(1), 43-66 (2007).
3. Hensley ML, Reichman BS. Fertility and pregnancy after adjuvant chemotherapy for breast cancer. Crit. Rev. Oncol. Hematol. 28(2), 121-128 (1998).
4. Warne GL, Fairley KF, Hobbs JB, Martin FI. Cyclophosphamide-induced ovarian failure. N. Engl. J. Med. 289(22), 1159-1162 (1973).
5. Sanders JE, Hawley J, Levy W et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 87(7), 3045-3052 (1996).
6. Meirow D. Ovarian injury and modern options to preserve fertility in female cancer patients treated with high dose radio-chemotherapy for hemato-oncological neoplasias and other cancers. Leuk. Lymphoma 33(1-2), 65-76 (1999).
7. Wallace WH, Thomson AB, Saran F, Kelsey TW. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int. J. Radiat. Oncol. Biol. Phys. 62(3), 738-744 (2005).
8. Wallace WH, Thomson AB, Kelsey TW. The radiosensitivity of the human oocyte. Hum. Reprod. 18(1), 117-121 (2003).
9. Anderson RA, Cameron DA. Pretreament serum anti-mullerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer. J. Clin. Endocrinol. Metab. 96(5), 1336-1343 (2011).
10. Sutton R, Buzdar AU, Hortobagyi GN. Pregnancy and offspring after adjuvant chemotherapy in breast cancer patients. Cancer 65 (4), 847-850 (1990).
11. Belinson JL, Doherty M, McDay JB. A new technique for ovarian transposition. Surg. Gynecol. Obstet. 159, 157-160 (1984). (Pubitemid 14055445)
12. Hodel K, Rich WM, Austin P, DiSaia PJ. The role of ovarian transposition in conservation of ovarian function in radical hysterectomy followed by pelvic radiation. Gynecol. Oncol. 13, 195-202 (1982). (Pubitemid 12104177)
13. Husseinzadeh N, Nahhas WA, Velkly DE, Whitney CW, Mortel R. The preservation of ovarian function in young women undergoing pelvic radiation therapy. Gynecol. Oncol. 18, 373-379 (1984). (Pubitemid 14095037)
14. Husseinzadeh N, van Aken ML, Aron B. Ovarian transposition in young patients with invasive cervical cancer receiving radiation therapy. Int. J. Gynecol. Cancer 4, 61-65 (1994). (Pubitemid 24012224)
15. Scott SM, Schlaff W. Laparoscopic medial oophoropexy prior to radiation therapy in an adolescent with Hodgkin's disease. J. Pediatr. Adol. Gynecol. 18, 355-357 (2005). (Pubitemid 41395255)
16. Williams RS, Littell RD, Mendenhall NP. Laparoscopic oophoropexy and ovarian function in the treatment of Hodgkin disease. Cancer 86, 2138-2142 (1999).
17. Badawy A, Elnashar A, Elshry M, Shahat M. Gonadotropin- releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study. Fertil. Steril. 91(3), 694-697 (2009).
18. Critchley HO, Wallace WH. Impact of cancer treatment on uterine function. J. Natl Cancer Inst. Monogr. (34), 64-68 (2005).
19. Clayton RN, Huhtaniemi IT. Absence of gonadotropin-releasing hormone receptors in human gonadal tissue. Nature 299(5878), 56-59 (1982).
20. Teinturier C, Hartmann O, Valteau-Couanet D, Benhamou E, Bougneres PF. Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure. Bone Marrow Transplant. 22(10), 989-994 (1998).
21. Ataya K, Pydyn E, Ramahitaya A, Orton CG. Is radiation-induced ovarian failure in rhesus monkeys preventable by luteinizing hormone-releasing hormone agonists?: Preliminary observations. J. Clin. Endocrinol. Metab. 80(3), 790-755 (1995).
22. Ataya K, Rao LV, Lawrence E, Kimmel R. Luteinizing hormone-releasing hormone agonist inhibits cyclophosphamide-induced ovarian follicular depletion in rhesus monkeys. Biol. Reprod. 52(2), 365-372 (1995).
23. Blumenfeld Z, Avivi I, Linn S, Epelbaum R, Ben-Shahar M, Haim N. Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy. Hum. Reprod. 11(8), 1620-1626 (1996).
24. Blumenfeld Z, Dann E, Avivi I, Epelbaum R, Rowe JM. Fertility after treatment for Hodgkin's disease. Ann. Oncol. 13(Suppl. 1), 138-147 (2002).
25. Waxman JH, Ahmed R, Smith D et al. Failure to preserve fertility in patients with Hodgkin's disease. Cancer Chemother. Pharmacol. 19(2), 159-162 (1987).
26. Clowse ME, Behera MA, Anders CK et al. Ovarian preservation by GnRH agonists during chemotherapy: a metanalysis.Women's Health 18(3), 311-319 (2009).
27. Beck-Fruchter R, Weiss A, Shalev E. GnRH therapy as ovarian protectants in female patients undergoing chemotherapy: a review of the clinical data. Hum. Reprod. Update 14(6), 553-561 (2008).
28. van der Kaaij MA, van Echtenrends J, Simons AH, Kluin-Nelemans HC. Fertility preservation after chemotherapy for Hodgkin lymphoma. Hematol Oncol. 28(4), 168-179 (2010).
29. Blumenfeld Z, Avivi I, Ritter M, Rowe JM. Preservation of fertility and ovarian function and minimizing chemotherapy-induced gonadotoxicity in young women. J. Soc. Gynecol. Investig. 6(5), 229-239 (1999).
30. Potolog-Nahari C, Fishman A, Cohen I. Protection of ovarian function and fertility using a combination of gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist during cancer treatment in young females. Gynecol. Endocrinol. 23(5), 290-294 (2007).
31. Lee SJ, Schover LR, Partridge AH et al. American society of clinical oncology recommendations on fertility preservation in cancer patients. J. Clin. Oncol. 24(18), 2917-2931 (2006).
32. Son WY, Yoon SH, Yoon HJ, Lee SM, Lim JH. Pregnancy outcome following transfer of human blastocysts vitrified on electron microscopy grids after induced collapse of the blastocoele. Hum. Reprod. 18(1), 137-139 (2003).
33. Wang JX, Yap YY, Matthews CD. Frozen-thawed embryo transfer: influence of clinical factors on implantation rate and risk of multiple conception. Hum. Reprod. 16(11), 2316-2319 (2001).
34. Senn A, Vozzi C, Chanson A, De Grandi P, Germond M. Prospective randomized study of two cryopreservation policies avoiding embryo selection: the pronucleate stage leads to a higher cumulative delivery rate than the early cleavage stage. Fertil. Steril. 74(5), 946-952 (2000).
35. Frederick JL, Ord T, Kettel LM, Stone SC, Balmaceda JP, Asch RH. Successful pregnancy outcome after cryopreservation of all fresh embryos with subsequent transfer into an unstimulated cycle. Fertil. Steril. 64(5), 987-990 (1995).
36. Selick CE, Hofmann GE, Albano C et al. Embryo quality and pregnancy potential of fresh compared with frozen embryos - is freezing detrimental to high quality embryos? Hum. Reprod. 10(2), 392-395 (1995).
37. Knopman JM, Noyes N, Talebian S, Krey LC, Grifo JA, Licciardi F. Women with cancer undergoing ART for fertility preservation: a cohort study of their response to exogenous gonadotropins. Fertil. Steril. 91(Suppl. 4), 1476-1478 (2009).
38. Azem F, Amit A, Merimsky O, Lessing JB. Successful transfer of frozen-thawed embryos obtained after subtotal colectomy for colorectal cancer and before fluorouracil-based chemotherapy. Gynecol. Oncol. 93(1), 263-265 (2004).
39. Robertson AD, Missmer SA, Ginsburg ES. Embryo yield after in vitro fertilization in women undergoing embryo banking for fertility preservation before chemotherapy. Fertil. Steril. 95(2), 588-591 (2011).
40. Sonmezer M, Oktay K. Fertility preservation in female patients. Hum. Reprod. Update 10(3), 251-266 (2004).
41. Azim AA, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J. Clin. Oncol. 26(16), 2630-2635 (2008).
42. Chen C. Pregnancy after human oocyte cryopreservation. Lancet 1(8486), 884-886 (1986).
43. Rienzi L, Romano S, Albricci L et al. Embryo development of fresh 'versus' vitrified metaphase II oocytes after ICSI: a prospective randomized sibling-oocyte study. Hum. Reprod. 25(1), 66-73 (2010).
44. Nugent D, Meirow D, Brook PF, Aubard Y, Gosden RG. Transplantation in reproductive medicine: previous experience, present knowledge and future prospects. Hum. Reprod. Update 3(3), 267-280 (1997).
45. Donnez J, Bassil S. Indications for cryopreservation of ovarian tissue. Hum. Reprod. Update 4(3), 248-259 (1998).
46. Oktay K, Economos K, Kan M, Rucinski J, Veeck L, Rosenwaks Z. Endocrine function and oocyte retrieval after autologous transplantation of ovarian cortical strips to the forearm. JAMA 286(12), 1490-1493 (2001).
47. Poirot C, Vacher-Lavenu MC, Helardot P, Guibert J, Brugières L, Jouannet P. Human ovarian tissue cryopreservation: indications and feasibility. Hum. Reprod. 17(6), 1447-1452 (2002).
48. Poirot CJ, Martelli H, Genestie C et al. Feasibility of ovarian tissue cryopreservation for prepubertal females with cancer. Pediatr. Blood Cancer 49(1), 74-78 (2007).
49. Demeestere I, Simon P, Englert Y, Delbaere A. Preliminary experience of ovarian tissue cryopreservation procedure: alternatives, perspectives and feasibility. Reprod. Biomed. Online 7(5), 572-579 (2003).
50. Oktay K, Sonmezer M. Ovarian tissue banking for cancer patients: fertility preservation, not just ovarian cryopreservation. Hum. Reprod. 19(3), 477-480 (2007).
51. Oktay K, Buyuk E. Fertility preservation in women undergoing cancer treatment. Lancet 363(9423), 1830 (2004).
52. Donnez J, Martinez-Madrid B, Jadoul P, van Langendonckt A, Demylle D, Dolmans MM . Ovarian tissue cryopreservation and transplantation: a review. Hum. Reprod. Update 12(5), 519-535 (2006). (Pubitemid 44288709)
53. Weintraub M, Gross E, Kadari A et al. Should ovarian cryopreservation be offered to girls with cancer. Pediatr. Blood Cancer 48(1), 4-9 (2007). (Pubitemid 44871585)
54. Meirow D, Baum M, Yaron R et al. Ovarian tissue cryopreservation in hematologic malignancy: ten years' experience. Leuk. Lymphoma 48(8), 1569-1576 (2007). (Pubitemid 47272807)
55. Hovatta O. Cryopreservation and culture of human primordial and primary ovarian follicles. Mol. Cell Endocrinol. 169(1-2), 95-97 (2000).
56. Donnez J, Dolmans MM, Demylle D et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 364(9443), 1405-1410 (2005).
57. Meirow D, Levron J, Eldar-Geva T et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N. Engl. J. Med. 353(3), 318-321 (2005). (Pubitemid 41058339)
58. Demeestere I, Simon P, Emiliani S, Delbaere A, Englert Y. Fertility preservation: successful transplantation of cryopreserved ovarian tissue in a young patient previously treated for Hodgkin's disease. Oncologist 12(12), 1437-1442 ( 2007).
59. Andersen CY, Rosendahl M, Byskov AG et al. Two successful pregnancies following autotransplantation of frozen/thawed ovarian tissue. Hum. Reprod. 23(10), 2266-2272 (2008).
60. Silber SJ, Lenahan KM, Levine DJ et al. Ovarian transplantation between monozygotic twins discordant for premature ovarian failure. N. Engl. J. Med. 353(1), 58-63 (2005). (Pubitemid 41007807)
61. Silber SJ, Grudzinskas G, Gosden RG. Successful pregnancy after microsurgical transplantation of an intact ovary. N. Engl. J. Med. 359(24), 2617-2618 (2008).
62. Silber SJ, Gosden RG. Ovarian transplantation in a series of monozygotic twins discordant for ovarian failure. N. Engl. J. Med. 356(13), 1382-1384 (2007). (Pubitemid 46513329)
63. Curtin JP, Barakat RR, Hoskins WJ. Ovarian disease in women with breast cancer. Obstet. Gynecol. 1994 84(3), 449-452 ( 1994). (Pubitemid 24267309)
64. Freud S. Das Ich und das Es, Internationaler Psychonalytischer Verlag, Leipzig, Vienna, and Zurich. English translation, The Ego and the Id. Hogarth Press and Institute of Psychonalysis, London, UK, (1927).
65. Ethics Committee of the American Society for Reproductive Medicine. Fertility preservation and reproduction in cancer patients. Fertil. Steril. 83(6), 1622-1628 (2005).
66. Robertson JA. Ethical issues in ovarian transplantation and donation. Fertil. Steril. 73(3), 443-446 (2000). (Pubitemid 30109635)
67. Faure-Pragier S. Les bébés de l' inconscient. Presse Universitaire de France, Paris, France (1997).
68. Quinn GP, Vadaparampil ST, Jacobsen PB et al. Frozen hope: fertility preservation for women with cancer. J. Midwifery Womens Health 55(2), 175-180 (2010).